FIELD: pharmacology.
SUBSTANCE: invention is a pharmaceutical composition of acetylsalicylic acid or a pharmaceutically acceptable salt thereof, omega-3 fatty acids, a pharmaceutically acceptable organic acid and amylose or starch containing 50 wt % to 70 wt % of amylose in soft gelatin capsules.
EFFECT: invention allows to obtain a composition with improved stability over time during storage, compared to soft gelatin capsules including pregelatinized starch in the capsule and in the core.
8 cl, 13 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ENTERIC-COATED SOFT CAPSULE AND METHOD FOR PRODUCING IT | 2014 |
|
RU2569742C1 |
| IMMERSION COATING COMPOSITIONS CONTAINING HIGH AMYLOSE STARCH | 2009 |
|
RU2486917C2 |
| DPA-ENRICHED COMPOSITIONS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN FREE ACID FORM | 2013 |
|
RU2664429C2 |
| COMPOSITIONS OF THE COMPLEXES OF OMEGA-3 FATTY ACIDS | 2013 |
|
RU2633862C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION COMPRISING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARING AND USING DOSAGE FORM BASED ON PHARMACEUTICAL COMPOSITION CONTAINING MELATONIN AND DIPHENHYDRAMINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2021 |
|
RU2818092C1 |
| SOFT GELATINOUS CAPSULE (VARIANTS) AND METHOD OF ITS MAKING | 1994 |
|
RU2140783C1 |
| STABLE PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USING THEM | 2010 |
|
RU2538691C2 |
| CAPSULAR FORM OF CLOFAZIMINE | 2013 |
|
RU2553310C2 |
| COMPOSITIONS OF STATINS AND OMEGA-3 FATTY ACIDS | 2013 |
|
RU2645075C2 |
